The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Travere Therapeutics, Inc. (NASDAQ: TVTX). ...
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.19%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.80%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.18%. March E-mini...
New PDUFA target action date is April 13, 2026 Commercial launch preparations continue in anticipation of potential approval
The S&P 500 Index ($SPX ) (SPY ) is down -0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.26%. March E-mini S&P futures (ESH26...
The S&P 500 Index ($SPX ) (SPY ) is down -0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.09%. March E-mini S&P futures (ESH26...
U.S. FILSPARI reaches all-time highs of 908 new PSFs and net product sales of approximately $103 million in 4Q 2025 Company positioned for successful commercial launch...
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present at the 44 th Annual J.P. Morgan Healthcare Conference...
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on December 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants to five new employees, consisting...
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on November 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants to three new employees, consisting...
New late-breaking data from DUPLEX Study show significantly more FILSPARI ® (sparsentan)-treated patients achieved proteinuria below 0.7 g/g compared with irbesartan ...